CDXS Covered Call Strategy

CDXS (Codexis, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Codexis, Inc. is a biotechnology firm dedicated to the discovery, development, and commercialization of enzymes and other protein-based solutions. Its diverse portfolio encompasses advanced biocatalyst products and related services, specialized chemical intermediates vital for subsequent processing steps, and proprietary biocatalyst panels and kits that empower clients to conduct effective chemistry screening. The company also extends its expertise through biocatalyst screening and sophisticated protein engineering services. Central to its operations is the proprietary CodeEvolver protein engineering technology platform. This innovative platform is instrumental in crafting and delivering high-performance biocatalysts capable of driving chemical transformations, thereby significantly enhancing the efficiency and productivity of manufacturing processes. Beyond industrial applications, the CodeEvolver platform is also leveraged for identifying novel biotherapeutic drug candidates for targeted human diseases, as well as for developing enzymes essential for molecular biology research and in vitro diagnostic applications.

CDXS (Codexis, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $172.1M, a beta of 2.50 versus the broader market, a 52-week range of 0.96-3.87, average daily share volume of 1.2M, a public-listing history dating back to 2010, approximately 146 full-time employees. These structural characteristics shape how CDXS stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 2.50 indicates CDXS has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.

What is a covered call on CDXS?

A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.

CDXS snapshot

As of August 14, 2026, spot at $1.58, ATM IV 272.50%, IV rank 63.92%, expected move 78.12%. The covered call on CDXS below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.

Why this covered call structure on CDXS specifically: CDXS IV at 272.50% is mid-range versus its 1-year history, so the credit collected on a CDXS covered call sits in line with its long-run distribution, with a market-implied 1-standard-deviation move of approximately 78.12% (roughly $1.23 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CDXS expiries trade a higher absolute premium for lower per-day decay. Position sizing on CDXS should anchor to the underlying notional of $1.58 per share and to the trader's directional view on CDXS stock.

CDXS covered call setup

The CDXS covered call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CDXS at $1.58 on that close, the first option leg uses a $1.66 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CDXS chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CDXS shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 100 sharesStock$1.58long
Sell 1Call$1.66N/A

CDXS covered call risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.

CDXS covered call payoff curve

Modeled P&L at expiration across a range of underlying prices for the covered call on CDXS. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use covered call on CDXS

Covered calls on CDXS are an income strategy run on existing CDXS stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.

CDXS thesis for this covered call

The market-implied 1-standard-deviation range for CDXS extends from approximately $0.35 on the downside to $2.81 on the upside. A CDXS covered call collects premium on an existing long CDXS position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether CDXS will breach that level within the expiration window. Current CDXS IV rank near 63.92% is mid-range against its 1-year distribution, so the IV signal is neutral; the covered call thesis on CDXS should anchor more to the directional view and the expected-move geometry. As a Healthcare name, CDXS options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CDXS-specific events.

CDXS covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CDXS positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CDXS alongside the broader basket even when CDXS-specific fundamentals are unchanged. Short-premium structures like a covered call on CDXS carry tail risk when realized volatility exceeds the implied move; review historical CDXS earnings reactions and macro stress periods before sizing. Always rebuild the position from current CDXS chain quotes before placing a trade.

Frequently asked questions

What is a covered call on CDXS?
A covered call on CDXS is the covered call strategy applied to CDXS (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With CDXS stock at $1.58 on the most recent close, the strikes shown on this page are snapped to the nearest listed CDXS chain strike and the premiums come straight from that session's bid/ask midpoint.
How are CDXS covered call max profit and max loss calculated?
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the CDXS covered call priced from the end-of-day chain at a 30-day expiry (ATM IV 272.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a CDXS covered call?
The breakeven for the CDXS covered call priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The CDXS market-implied 1-standard-deviation expected move in the same options snapshot is approximately 78.12%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a covered call on CDXS?
Covered calls on CDXS are an income strategy run on existing CDXS stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
How does current CDXS implied volatility affect this covered call?
CDXS ATM IV is at 272.50% with IV rank near 63.92%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

Related CDXS analysis